Press release
13.12.2024 To the attention of interested persons Alofisel withdrawn from the EU market download document …
Press release
09.12.2024 To the attention of interested persons ETF statement on the loss of activity of anti-spike protein monoclonal antibodies due […]
Press release
29.11.2024 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 November 2024 download […]
Press release
15.11.2024 To the attention of interested persons Updated advice to minimise risks of interaction between weight loss medicine Mysimba and […]
Press release
14.11.2024 To the attention of interested persons Leqembi recommended for treatment of early Alzheimer’s disease download document …
Important notification
12.11.2024 To the attention of economic operators approved by the National Agency for Medicines and Medical Devices of Romania who […]
Important notification
01.11.2024 To the attention of manufacturers and all interested stakeholders Please be informed that on 30.10.2024, the European Commission published […]
Important notification
24.10.2024 To the attention of professional users of medical devices We inform you that starting with 24.10.2024, the provisions of […]
Important notification
18.10.2024 To the attention of interested persons Starting with 21.10.2024, the activity of registration and issuance of documents, including for […]
Press release
18.10.2024 To the attention of interested persons Translarna: EMA re-confirms non-renewal of authorisation of Duchenne muscular dystrophy medicine download document […]